A double‐blind, placebo‐controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Aims To assess whether fexofenadine in a range of doses from 80 to 180 mg has any disruptive effects on aspects of psychomotor and cognitive function in comparison with placebo, loratadine and promethazine, an antihistamine known to produce psychomotor and cognitive impairment. Methods Twenty‐four healthy volunteers received fexofenadine 80 mg, 120 mg and 180 mg, loratadine 10 mg, promethazine 30 mg (as a positive internal control) and placebo in a six‐way crossover, double‐blind study. Following each dose, subjects were required to perform a series of tests of cognitive function and psychomotor performance at 1.5, 3, 6, 9, 12 and 24 h post dose. The test battery included critical flicker fusion (CFF), choice reaction time (CRT) and assessment of subjective sedation (LARS). Overall levels of activity were monitored by means of wrist mounted actigraphs throughout each of the 24 h experimental periods. Results Fexofenadine at all doses tested was not statistically different from placebo in any of the tests used and loratadine did not cause any significant impairment of cognitive function. Significant impairments were found following promethazine. Promethazine caused a significant reduction in CFF threshold and this effect was evident up to 12 h post dose (P<0.05). There was a significant increase in recognition reaction time at 3 and 6 h post promethazine administration, and the drug caused a significant (P<0.002) increase in the percentage of ‘sleep‐like’ activity from actigraph records during the daytime. Conclusions Fexofenadine at doses up to 180 mg appears free from disruptive effects on aspects of psychomotor and cognitive function in a study where the psychometric assessments have been shown to be sensitive to impairment, as evidenced by the effects of the verum control promethazine 30 mg.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peripheral H1-Blockade Effect of Fexofenadine
Simons, F. E. R., & Simons, K. J. (1997) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63061-x · Cited by 55
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W., & Pollak, C. P. (2003) · Sleep · doi:10.1093/sleep/26.3.342 · Cited by 2,751
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A., & Häussinger, D. (2002) · Hepatology · doi:10.1053/jhep.2002.30957 · Cited by 397
The Economic Burden of Allergic Rhinitis: A Critical Evaluation of the Literature
Reed, S. D., Lee, T. A., & McCrory, D. C. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422060-00002 · Cited by 222
Metadata
- Authors
- Hindmarch, I., Shamsi, Z., Stanley, N., & Fairweather, D. B.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1999-08
- Volume
- 48
- Issue
- 2
- Pages
- 200-206
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1756057165
- Cited by
- 101
- References
- 1
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double‐blind, placebo‐controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. https://app.cochat.ai/papers/10.1046/j.1365-2125.1999.00993.x
- The paper
- Hindmarch, I., Shamsi, Z., Stanley, N., & Fairweather, D. B. (1999). A double‐blind, placebo‐controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.1365-2125.1999.00993.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.